These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8326 related articles for article (PubMed ID: 21277538)

  • 1. New therapeutic options in the medical management of advanced melanoma.
    Lutzky J
    Semin Cutan Med Surg; 2010 Dec; 29(4):249-57. PubMed ID: 21277538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma genetics: the other side.
    Bis S; Tsao H
    Clin Dermatol; 2013; 31(2):148-55. PubMed ID: 23438378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel treatment strategies for malignant melanoma: a new beginning?
    Kasper B; D'Hondt V; Vereecken P; Awada A
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):16-22. PubMed ID: 17208006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kinase inhibitors for the therapy of malignant melanoma].
    Becker JC; Schrama D; Bröcker EB; Houben R
    J Dtsch Dermatol Ges; 2005 Oct; 3(10):762-7. PubMed ID: 16194153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant melanoma: molecular cytogenetics and their implications in clinical medicine.
    Junkins-Hopkins JM
    J Am Acad Dermatol; 2010 Aug; 63(2):329-32. PubMed ID: 20633801
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic treatment of malignant melanoma.
    Mota A; Deisseroth A
    Clin Plast Surg; 2000 Jul; 27(3):463-74, x. PubMed ID: 10941566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenetics of melanoma: basis for molecular diagnostics and therapy.
    Held L; Eigentler TK; Meier F; Held M; Röcken M; Garbe C; Bauer J
    J Dtsch Dermatol Ges; 2011 Jul; 9(7):510-6. PubMed ID: 21244632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drug targets in metastatic melanoma.
    Homet B; Ribas A
    J Pathol; 2014 Jan; 232(2):134-41. PubMed ID: 24027077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in targeted therapy for unresectable melanoma: new drugs and combinations.
    Hao M; Song F; Du X; Wang G; Yang Y; Chen K; Yang J
    Cancer Lett; 2015 Apr; 359(1):1-8. PubMed ID: 25578781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unveil the mysterious mask of cytokine-based immunotherapy for melanoma.
    Xu DH; Zhu Z; Xiao H; Wakefield MR; Bai Q; Nicholl MB; Ding VA; Fang Y
    Cancer Lett; 2017 May; 394():43-51. PubMed ID: 28254411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?
    Lorigan P; Eisen T; Hauschild A
    Exp Dermatol; 2008 May; 17(5):383-94. PubMed ID: 18312390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for non-immunological molecular therapeutics in melanoma.
    Eustace AJ; Mahgoub T; Tryfonopoulos D; O'Donovan N; Crown J
    J BUON; 2010; 15(1):9-18. PubMed ID: 20414921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecularly targeted therapy for melanoma: current reality and future options.
    Becker JC; Kirkwood JM; Agarwala SS; Dummer R; Schrama D; Hauschild A
    Cancer; 2006 Nov; 107(10):2317-27. PubMed ID: 17039502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of metastatic melanoma 2005.
    O'Day S; Boasberg P
    Surg Oncol Clin N Am; 2006 Apr; 15(2):419-37. PubMed ID: 16632224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapeutical strategies in the treatment of metastatic disease.
    Julia F; Thomas L; Dalle S
    Dermatol Ther; 2012; 25(5):452-7. PubMed ID: 23046024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular patterns in melanoma and therapeutic targets.
    Chua RA; Arbiser JL
    G Ital Dermatol Venereol; 2010 Oct; 145(5):597-602. PubMed ID: 20930694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy and chemoimmunotherapy for metastatic malignant melanoma: review and recent advances.
    Khayat D; Coeffic D
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():238-47. PubMed ID: 10895160
    [No Abstract]   [Full Text] [Related]  

  • 18. Major therapeutic developments and current challenges in advanced melanoma.
    Sullivan RJ; Flaherty KT
    Br J Dermatol; 2014 Jan; 170(1):36-44. PubMed ID: 24443912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for the development of more effective adjuvant therapy of melanoma: current and future explorations of antibodies, cytokines, vaccines, and combinations.
    Kirkwood JM; Moschos S; Wang W
    Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2331s-2336s. PubMed ID: 16609054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations and personalized medicine in melanoma: progress and future prospects.
    Griewank KG; Scolyer RA; Thompson JF; Flaherty KT; Schadendorf D; Murali R
    J Natl Cancer Inst; 2014 Feb; 106(2):djt435. PubMed ID: 24511108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 417.